About Jonathan Lakey
Form D filings for XOStem Biosciences in 2024 list Jonathan Lakey as executive officer and director.
Jonathan Lakey first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Lakey in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Lakey works with at each company, as listed on that company's latest Form D.
XOStem Biosciences Ltd. · Form D, Feb 29, 2024
CF
Chad Friesen
Director
AM
Alex McAulay
CFO and director